Cannabis finance news

Bioxyne lifts FY26 guidance after margin growth in strong first half

by Steve Jones February 26, 2026February 26, 2026

Shares in medicinal cannabis pastille manufacturer Bioxyne climbed more than 13% today after lifting its FY26 […]

Vitura Health reports first-half loss as price war continues to hit margins

by Steve Jones February 25, 2026February 25, 2026

Nexalis outlines 2026 plan as IRX shares jump 35%

by Adam Sheldon February 17, 2026February 19, 2026

Cannim liquidator draws up timeframe for potential litigation and court-ordered director examinations

by Steve Jones February 10, 2026February 10, 2026

Tensions run high as creditors vote to wind up Cannim Group

by Steve Jones February 5, 2026February 5, 2026

Cannatrek ‘evolution’ key to merger, says LGP managing director

by Adam Sheldon February 3, 2026February 5, 2026

Financial news in brief: Avecho; InhaleRx; Neurotech; Peak; Zelira; Argent

by Adam Sheldon February 2, 2026June 8, 2026

Elixinol records first underlying operating cash flow positive quarter

by Adam Sheldon February 2, 2026February 3, 2026

Cann Group to review guidance after starting post-NAB era with ‘unexpectedly’ soft revenue

by Steve Jones January 30, 2026February 3, 2026

European growth helps LGP report record quarter of revenue

by Steve Jones January 30, 2026February 3, 2026